Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Starting dose for Tirzepatide: 2.5 mg weekly = 15 units (0.15 mL) on the insulin syringe provided
Semaglutide currently has stronger evidence for heart health, making it the preferred option for patients with existing cardiovascular disease
Oral formulations can also break through plateaus for patients who experienced reduced absorption or injection-site tissue changes with injectable tirzepatide
The systematic review revealed a cost-effective profile of using GLP-1RAs versus insulin
These came in multi-dose vials, custom strengths, and sometimes combinations with B-vitamins, at a significantly lower price than brand-name options
US$ 24.25
US$ 21.72
US$ 24.66
US$ 21.94
US$ 27.50
